HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuhide Yamazaki Selected Research

lipoarabinomannan (LAM)

9/2008Successful treatment with lamivudine may correlate with reduction of serum ferritin levels in the patients with chronic hepatitis and liver cirrhosis type B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuhide Yamazaki Research Topics

Disease

2Hepatocellular Carcinoma (Hepatoma)
01/2009 - 02/2008
2Chronic Hepatitis B
09/2008 - 06/2007
1Hepatitis B
03/2009
1Jaundice (Icterus)
03/2009
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2009
1Anorexia
03/2009
1Infections
09/2008
1Chronic Hepatitis (Chronic Active Hepatitis)
09/2008
1Liver Cirrhosis (Hepatic Cirrhosis)
09/2008
1Siderosis
09/2008
1Hemosiderosis
09/2008
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
04/2008

Drug/Important Bio-Agent (IBA)

2Lamivudine (Epivir)FDA Link
03/2009 - 09/2008
2InterferonsIBA
02/2008 - 06/2007
1Rituximab (Mabthera)FDA Link
03/2009
1Cyclin-Dependent Kinase Inhibitor p16IBA
01/2009
1IronIBA
09/2008
1Ferritins (Ferritin)IBA
09/2008
1lipoarabinomannan (LAM)IBA
09/2008
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
04/2008
1Interferon-betaIBA
02/2008
1Surface Antigens (Surface Antigen)IBA
06/2007
1Ribavirin (Virazole)FDA LinkGeneric
06/2007
1Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2007

Therapy/Procedure

1VAP-cyclo protocol
03/2009
1Therapeutics
03/2009